Baptist Health Heart & Vascular Care Hosts ECMO Boot Camp for Clinicians - Scorecard - MDSpire

Baptist Health Heart & Vascular Care Hosts ECMO Boot Camp for Clinicians

Baptist Health Heart & Vascular Care recently hosted the BHSF–UPMC ECMO Boot Camp at the Education Center at Baptist Health Baptist Hospital.

  • By

  • May 26, 2026

  • 2 min

Share

Clinical Scorecard: Baptist Health Heart & Vascular Care Hosts ECMO Boot Camp for Clinicians

At a Glance

CategoryDetail
ConditionExtracorporeal Membrane Oxygenation (ECMO)
Key MechanismsMechanical circulatory support and bedside management
Target PopulationClinicians in South Florida
Care SettingBaptist Health Education Center

Key Highlights

  • Two-day advanced training for clinicians
  • Focus on ECMO cannulation and circuit management
  • Hands-on education with high-fidelity simulation
  • Collaboration with the University of Pittsburgh Medical Center
  • Led by Dr. I-wen Wang, cardiothoracic surgeon

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Patients requiring advanced cardiovascular care

          Strengthening clinical readiness and collaboration for complex care

          Clinical Best Practices

          • Enhance collaboration across multidisciplinary teams
          • Invest in specialized cardiovascular care training
          • Utilize high-fidelity simulation for skill development

          Related Resources & Content

          Original Source(s)

          Baptist Health Heart & Vascular Care Hosts ECMO Boot Camp for Clinicians

          • by

          • May 26, 2026

          Related Content

          AD Not Linked to Early CV Risk Markers

          Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

          Non-Invasive Testing for Coronary Artery Disease

          Dr. Uprety discusses the current role of non-invasive testing for coronary artery disease, highlighting evidence-based diagnostic strategies and the appropriate use of imaging modalities to improve early detection, risk stratification, and clinical decision-making.

          • May 18, 2026

          FDA Approves Baxdrostat for Resistant Hypertension

          Phase 3 findings support the oral therapy in adults with persistent blood pressure elevation despite multidrug treatment.